2 Super-Charged Growth Stocks to Buy Now
Growth stocks can be a thing of beauty. These types of equities can linger in your portfolio for years without doing much. Then one day, they can double or even triple in value within a matter of hours. The trick, if you will, is to suss out growth stocks that won't rot on the vine, so to speak.
Which super-charged growth stocks should investors buy right now? I'm a big fan of both BioCryst Pharmaceuticals (NASDAQ: BCRX) and ChemoCentryx (NASDAQ: CCXI). While both of these biotech stocks have more than doubled in value in the past three years, I believe each of these healthcare equities still has a lot of room to run in 2022 and beyond. Here's why.
Image source: Getty Images.
Source Fool.com
